Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?
Hasitha ManoharAdam S PotterEfstratios KoutroumpakisAnita DeswalNicolas L PalaskasPublished in: Current atherosclerosis reports (2022)
The pathophysiology behind how traditional cardiovascular risk factors also contribute to cancer development and mortality is increasingly recognized. In addition, newer cancer therapies, such as immune checkpoint inhibitors, cause increased inflammation leading to increased cardiovascular events. Traditional coronary heart disease risk factors such as obesity, hypertension, diabetes, and hyperlipidemia also contribute to cancer development and worse cancer outcomes. Cancer therapeutics can also lead to atherosclerotic events in addition to the shared risk factors present at the time of cancer diagnosis. Understanding the pathophysiology, using multidisciplinary care teams, and developing machine learning algorithms for individualized patient care will help to mitigate the risk of coronary heart disease in patients with cancer.
Keyphrases
- papillary thyroid
- cardiovascular events
- machine learning
- risk factors
- squamous cell
- cardiovascular risk factors
- type diabetes
- cardiovascular disease
- metabolic syndrome
- coronary artery disease
- oxidative stress
- childhood cancer
- palliative care
- insulin resistance
- artificial intelligence
- high fat diet
- weight loss
- physical activity
- big data
- quality improvement
- pain management
- chronic pain
- health insurance